RecruitingNCT06406933

Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome

Saliva Conductivity as A Novel Screening Test for Dry Eye Disease and Sjögren's Syndrome


Sponsor

Chang Gung Memorial Hospital

Enrollment

200 participants

Start Date

Jul 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Dry eye disease, or keratoconjunctivitis sicca, is one of the most common diseases encountered at ophthalmologic clinics. Patient with dry eye disease commonly presented foreign body sensation, red eye, blurred vision, etc. Numerous treatments for dry eye disease are proposed due to its multifactorial etiology. Sjögren syndrome, which is one of the main etiologies of dry eye disease, is an autoimmune disease characterized by dysfunction of lacrimal and salivary glands. Although dry eye status can be easily examined by ocular surface staining, the methods quantifying salivary flow rate are hard to performed clinically, such as salivary gland scintigraphy and sialometry. Furthermore, disease activity could only rely on serum markers or salivary gland ultrasound. Recently, a portable device measuring salivary conductivity is believed to assess fluid status and renal function. Interestingly, the composition of salivary electrolytes in patients with Sjögren syndrome is different from those with other causes of hyposalivation. Thus, this study aims to evaluate whether salivary conductivity in combination with ocular surface staining can be a non-invasive diagnostic test for primary Sjögren syndrome among people with dry eye disease.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether measuring the salt concentration (conductivity) of saliva can serve as a quick, non-invasive way to screen for dry eye disease and Sjögren's syndrome — an autoimmune condition that causes dry eyes and dry mouth. **You may be eligible if...** - You are 20 years of age or older - You have been diagnosed with dry eye syndrome, or your eyes are currently healthy (for comparison) **You may NOT be eligible if...** - You have hepatitis C, HIV/AIDS, lymphoma, rheumatoid arthritis, lupus, or other autoimmune diseases - You have had radiation therapy to the head or neck - You have glaucoma or a history of eye infections or eye surgery - You wore contact lenses in the past month - You smoked or chewed betel nuts in the past month Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCarbomer Gel/Jelly

The drug is for dry eye syndrome by providing temporary relief from discomfort and irritation.


Locations(1)

Department of Ophthalmology, Chang Gung Memorial Hospital

Pizi, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06406933


Related Trials